Zirakpur
08048035037
What PGT Can Add Before Choosing Embryo Transfer in Zirakpur

Choosing an embryo for transfer involves more than counting embryos or reading an IVF report. By the end, you will know which PGT category addresses your situation, how biopsy and freezing change the treatment sequence, what results can and cannot tell you, and which questions to ask before consenting.

Key takeaways

  • Choose PGT-A, PGT-M or PGT-SR based on the genetic question involved.
  • Embryos need biopsy, vitrification, laboratory testing and later thawing before transfer.
  • A euploid result differs from mosaic, aneuploid and no-result findings.
  • Use embryo results alongside age, embryo quality, uterine assessment and medical history.

Which PGT test matches your genetic concern?

The right PGT test depends on the genetic concern you are trying to address, not simply on undergoing IVF.

TestExaminesCannot establish
PGT-AExtra or missing chromosomes, called aneuploidyIt cannot replace PGT-M for a known familial pathogenic variant.
PGT-MA specified single-gene disorder linked to a known pathogenic variantIt does not screen for every inherited condition.
PGT-SRUnbalanced products of structural rearrangements, including reciprocal translocations, Robertsonian translocations, and inversionsIt does not prove that an embryo is normal in every genetic respect.

PGD is an older umbrella term often used for testing a known inherited disorder. Clinics now commonly discuss that work as PGT-M because “monogenic” identifies the modern single-gene category more precisely.

You have a stronger reason to discuss testing if your family carries an inherited condition, you had a previous affected pregnancy, one partner has a balanced translocation, or you have repeated pregnancy loss or IVF failure. An age-related concern about aneuploidy also warrants a PGT-A discussion.

Searching for pgt for benefits before embryo transfer in zirakpur or embryo genetic testing benefits in zirakpur should not be mistaken for proof that testing suits every patient.

Routine PGT-A for every IVF patient has less compelling evidence. It has not been shown to improve cumulative live-birth rates for every patient, so ask what outcome the proposed test is intended to change.

What happens between egg retrieval and embryo transfer?

The sequence starts with IVF treatment, not a blood test: PGT happens only after embryos have been created and grown in the laboratory. Anyone researching pgt before embryo transfer in zirakpur should expect several separate laboratory steps.

1. Ovarian stimulation uses medicines to develop multiple follicles. Egg retrieval then collects the eggs through a guided procedure.

2. The eggs are fertilised through conventional IVF or ICSI, in which one sperm is injected into each mature egg. The resulting embryos are cultured in the laboratory.

3. Embryos are grown to the blastocyst stage, usually on day 5 or day 6. The embryologist removes a small group of cells from the blastocyst’s outer layer, called the trophectoderm; the inner cell mass remains to develop into the fetus.

4. The biopsy sample is shipped to a genetics laboratory for DNA analysis. Meanwhile, the embryo is vitrified and stored. The biopsy and transfer are separate because genetic analysis needs time, so a fresh transfer is usually not possible after biopsy.

5. After results, a later frozen embryo transfer cycle prepares the uterine lining. The embryologist matches the selected embryo using its laboratory record, container or straw label, and cryostorage documentation.

Extended culture, biopsy, and thawing add handling and risk: an embryo can stop developing, produce no result, or fail to survive thawing. Ask for blastocyst-formation, biopsy-result-failure, and post-thaw-survival rates, not one headline rate, before choosing preimplantation testing before ivf in zirakpur.

How PGT-M and PGT-SR preparation differs from PGT-A

PGT-A can often be scheduled within the IVF laboratory’s chromosome-screening workflow. PGT-M and PGT-SR need risk-specific preparation before ovarian stimulation begins.

TestPreparation before stimulationResult assessed
PGT-AConfirm the IVF laboratory’s chromosome-screening workflowExtra or missing chromosome copies
PGT-MConfirm the familial pathogenic variant; examine linked DNA markers and build a family-specific test and probeThe specified single-gene condition
PGT-SRReview the carrier partner’s karyotype and design a method to identify unbalanced rearrangementsUnbalanced products of a translocation or inversion

For PGT-M, the genetics laboratory may request blood from both prospective parents, DNA from an affected relative, or samples from other relatives. These samples help build and validate the test. Ask what happens if family DNA is unavailable.

For PGT-SR, ask whether the method can distinguish embryos with an unbalanced rearrangement from embryos with other results, including carrier or balanced embryos. The laboratory must define the exact condition or rearrangement being assessed before treatment.

Do not start injections until you know whether test development, sample collection, validation, and reporting fit your treatment schedule. This matters when comparing preimplantation testing before IVF in Zirakpur or reviewing PGT treatment details in Zirakpur.

PGT does not create more embryos or correct an abnormality. An IVF cycle can produce no blastocyst suitable for biopsy, leaving no embryo to test or transfer.

What an euploid, aneuploid, mosaic, or no-result report means

A transfer decision depends on which report you receive, but none of the four categories proves that an embryo will implant or produce a healthy baby.

ReportWhat the biopsy showedTransfer meaning
EuploidExpected chromosome copy number for the chromosomes assessedUsually receives the highest transfer priority, but it is not a guarantee.
AneuploidAn abnormal chromosome copy number was detectedUsually not recommended for transfer; discuss the specific finding with a genetics professional.
MosaicThe biopsy contained cell lines with differing chromosome resultsNot automatically unusable. Some mosaic embryos have produced healthy births, but implantation and ongoing-pregnancy outcomes are more uncertain than with euploid embryos.
No-result or inconclusiveInformation was insufficient, failed, or uninterpretableIt is not proof that the embryo is affected; ask whether re-biopsy or another plan is appropriate.

Laboratories use different mosaic thresholds, labels, and transfer priorities. Genetic counselling matters because a “mosaic” result is not a simple yes-or-no answer.

Only a few trophectoderm cells are tested, not the entire embryo or future fetus. Cell differences, sampling error, biopsy limits, false-positive or false-negative results, and laboratory failure can create a result that does not match every cell. PGT cannot guarantee implantation, an ongoing pregnancy, or a healthy baby.

The practical question behind embryo genetic testing benefits in zirakpur is what this added information changes for you. Ask about pgt for benefits before embryo transfer in zirakpur alongside the test’s limits, handling of mosaic or no-result embryos, and the need for recommended prenatal testing.

What information should guide your transfer decision in Zirakpur?

PGT before embryo transfer in Zirakpur is a trade-off, not an automatic IVF step. It adds biopsy, freezing, laboratory cost and waiting time, and a cycle can end with no transferable embryo.

It may avoid transferring an embryo affected by the tested condition, reduce embryos transferred, and in selected patients reduce miscarriage or shorten time to live birth. It does not improve every patient’s cumulative live-birth chance.

Before consenting, ask:

  1. What test is planned: PGT-A, PGT-M or PGT-SR; which chromosomes, pathogenic variant or rearrangement will it assess?
  2. Do both parents, an affected relative or other family members need to provide blood or DNA samples? Ask how test development and validation affect the schedule.
  3. How many blastocysts are expected, when will trophectoderm biopsy occur, and how will each embryo be frozen, labelled and tracked?
  4. What is the reporting time, and what happens to mosaic, no-result or inconclusive embryos?
  5. What cancellation rules apply if no blastocyst forms, biopsy fails, all embryos are affected or aneuploid, or too few embryos make testing unhelpful?
  6. What are the clinic’s own rates for blastocyst formation, biopsy failure, thaw survival, implantation and live birth?

Kore Fertility Centre can help patients seeking PGT treatment details in Zirakpur, but ask the clinic and genetics laboratory to define the test’s scope and follow-up plan.

Prenatal care remains necessary: discuss chorionic-villus sampling or amniocentesis with your doctor or genetic counsellor, alongside ultrasound and routine antenatal screening, because PGT cannot assess every chromosomal, genetic, developmental or structural condition.

Related services

Preimplantation Genetic Testing (PGT)

Preimplantation Genetic Testing (PGT)

Preimplantation Genetic Testing (PGT) at Kore Fertility Centre is an advanced diagnostic procedure performed during an IVF cycle to evaluate the...

View service →

Preimplantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD)

Preimplantation Genetic Diagnosis (PGD) at Kore Fertility Centre is an advanced genetic testing procedure performed during an IVF cycle to identify...

View service →

Frequently asked questions

  • Which PGT test matches your genetic concern?

    PGT-A evaluates chromosome-number changes. PGT-M targets a known single-gene condition in the family. PGT-SR evaluates embryos when a parent has a structural chromosome rearrangement, such as a translocation or inversion.

  • What happens between egg retrieval and embryo transfer?

    The laboratory fertilises the eggs, grows embryos to the blastocyst stage, removes a small group of cells for biopsy, vitrifies the embryos, sends the samples for testing, and schedules transfer after the results and uterine preparation are reviewed.

  • How does PGT-M or PGT-SR preparation differ from PGT-A?

    PGT-A usually uses a chromosome-screening workflow. PGT-M requires a family-specific test setup for the known gene variant, while PGT-SR requires a test design based on the parent’s chromosome rearrangement. Both need genetic records and planning before egg retrieval.

  • What do euploid, aneuploid, mosaic and no-result reports mean?

    Euploid describes the expected chromosome copy number in the tested cells. Aneuploid indicates a chromosome-number abnormality. Mosaic means the biopsy contains cell lines with different chromosome findings. No-result means the test did not produce a usable interpretation and requires a discussion of next steps.

  • What should guide your embryo transfer decision in Zirakpur?

    Review the PGT report with a fertility specialist and, when relevant, a genetic counsellor. Consider the test’s limits, embryo quality, age, uterine assessment, previous IVF or pregnancy history, and whether repeat biopsy or another embryo is appropriate.

Oct 16th, 2026 10:35 AM

Keywords